ID
29110
Beschrijving
Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage
Trefwoorden
Versies (4)
- 22-02-18 22-02-18 -
- 24-02-18 24-02-18 -
- 25-02-18 25-02-18 -
- 17-09-21 17-09-21 -
Houder van rechten
gsk
Geüploaded op
25 februari 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Ropinirole Case Report Form GSK RRL100013
Subject diary
Beschrijving
Subject Instructions
Beschrijving
Bring this diary and any unused study medication with you to your next clinic visit Enter the information in the diary every day as required Print neatly and legibly Use ink, preferably black, to complete the information in the diary If you make a mistake: Draw a single line through the incorrect entry and write the correct data nearby Do not "write over" or erase an incorrect entry Do not use correction materials, such as correction fluid or tape, on this diary Page 2 FINAL - 24 SEP 04 If you have questions or concerns, contact the study contact person listed on the front of the diary
Datatype
text
Alias
- UMLS CUI [1,1]
- C3890583
- UMLS CUI [1,2]
- C0205197
- UMLS CUI [1,3]
- C0034394
Beschrijving
Patient global improvement scale instrucitons
Datatype
text
Alias
- UMLS CUI [1]
- C3639888
Beschrijving
You will take 2 doses of study medication every day. You should generally take your first dose 1 hour prior to when your RLS symptoms usually start. Your second dose should be taken at bedtime and at least 3 hours after the first dose. You should try to take your second dose within 6 hours of the first dose, as longer time frames between doses (e.g., 8 hours or more) may lead to the reoccurrence of RLS symptoms.
Datatype
text
Beschrijving
Dosing information
Alias
- UMLS CUI-1
- C0678766
Beschrijving
Dosage given:___________ Tablet x ___________ mg
Datatype
text
Alias
- UMLS CUI [1]
- C0178602
Beschrijving
Date and time of dosing
Datatype
datetime
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0011008
- UMLS CUI [1,4]
- C0040223
Beschrijving
dose administered by
Datatype
text
Alias
- UMLS CUI [1]
- C2348343
Beschrijving
Dose checked and witnessed by
Datatype
text
Alias
- UMLS CUI [1,1]
- C0682356
- UMLS CUI [1,2]
- C1283174
- UMLS CUI [1,3]
- C0178602
Beschrijving
Comments
Datatype
text
Alias
- UMLS CUI [1]
- C0947611
Beschrijving
Patient rated scale
Alias
- UMLS CUI-1
- C0681889
- UMLS CUI-2
- C1578483
Beschrijving
If the patient is eligible to continue in the study please continue the assessments for this visit as stated below: Remove the appropriate scales from the Patient Reported Outcomes Questionnaire Book and ask the patient to complete them in the following order: • RLS Quality of Life Questionnaire • SF36 Health Status Survey • Medical Outcome Study Sleep Scale • Work Productivity and Activity Impairment Questionnaire
Datatype
text
Alias
- UMLS CUI [1,1]
- C0034394
- UMLS CUI [1,2]
- C0034380
- UMLS CUI [1,3]
- C0035258
Beschrijving
If the patient is eligible to continue in the study please continue the assessments for this visit as stated below: Remove the appropriate scales from the Patient Reported Outcomes Questionnaire Book and ask the patient to complete them in the following order: • RLS Quality of Life Questionnaire • SF36 Health Status Survey • Medical Outcome Study Sleep Scale • Work Productivity and Activity Impairment Questionnaire
Datatype
text
Alias
- UMLS CUI [1]
- C3640521
Beschrijving
If the patient is eligible to continue in the study please continue the assessments for this visit as stated below: Remove the appropriate scales from the Patient Reported Outcomes Questionnaire Book and ask the patient to complete them in the following order: • RLS Quality of Life Questionnaire • SF36 Health Status Survey • Medical Outcome Study Sleep Scale • Work Productivity and Activity Impairment Questionnaire
Datatype
text
Alias
- UMLS CUI [1,1]
- C0349674
- UMLS CUI [1,2]
- C0037313
Beschrijving
If the patient is eligible to continue in the study please continue the assessments for this visit as stated below: Remove the appropriate scales from the Patient Reported Outcomes Questionnaire Book and ask the patient to complete them in the following order: • RLS Quality of Life Questionnaire • SF36 Health Status Survey • Medical Outcome Study Sleep Scale • Work Productivity and Activity Impairment Questionnaire
Datatype
text
Alias
- UMLS CUI [1]
- C3639722
Beschrijving
DOSING DETAILS
Alias
- UMLS CUI-1
- C0678766
Beschrijving
You will take 2 doses of study medication every day. You should generally take your first dose 1 hour prior to when your RLS symptoms usually start. Your second dose should be taken at bedtime and at least 3 hours after the first dose. You should try to take your second dose within 6 hours of the first dose, as longer time frames between doses (e.g., 8 hours or more) may lead to the reoccurrence of RLS symptoms
Datatype
text
Alias
- UMLS CUI [1,1]
- C1442085
- UMLS CUI [1,2]
- C0678766
Beschrijving
Dosage given:___________ Tablet x ___________ mg
Datatype
text
Alias
- UMLS CUI [1]
- C0178602
Beschrijving
Date and time of dosing
Datatype
datetime
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0011008
- UMLS CUI [1,4]
- C0040223
Beschrijving
dose administered by
Datatype
text
Alias
- UMLS CUI [1]
- C2348343
Beschrijving
Dose checked and witnessed by
Datatype
text
Alias
- UMLS CUI [1,1]
- C0682356
- UMLS CUI [1,2]
- C1283174
- UMLS CUI [1,3]
- C0178602
Beschrijving
Comments
Datatype
text
Alias
- UMLS CUI [1]
- C0947611
Beschrijving
Actigraphy Information
Alias
- UMLS CUI-1
- C1171301
Beschrijving
(to be completed by study coordinator prior to giving diary to patient e.g. Monday, Tuesday)
Datatype
date
Maateenheden
- Day Month Year
Alias
- UMLS CUI [1,1]
- C0677547
- UMLS CUI [1,2]
- C0240526
- UMLS CUI [1,3]
- C0442592
Beschrijving
Was the device with the "Right" label worn on Right leg Actigraphy Information
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1171301
- UMLS CUI [1,2]
- C0230442
Beschrijving
Was the device with the "Left" label worn on Left leg Actigraphy Information
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1171301
- UMLS CUI [1,2]
- C0230443
Beschrijving
AM or PM (circle one)
Datatype
time
Alias
- UMLS CUI [1]
- C4289366
Beschrijving
____ AM or PM (circle one)
Datatype
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C1170730
Similar models
Subject diary
C0040223 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0332189 (UMLS CUI [1,4])
C0035258 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,3])
C0001288 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C1457887 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2])
C1457887 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2])
C0392760 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0037317 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,2])
C0034394 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C1283174 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0034380 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0037313 (UMLS CUI [1,2])
C0678766 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C1283174 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0240526 (UMLS CUI [1,2])
C0442592 (UMLS CUI [1,3])
C0230442 (UMLS CUI [1,2])
C0230443 (UMLS CUI [1,2])
C1170730 (UMLS CUI [1,2])